Published TCIMAIL newest issue No.196
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 84057-95-4 | Product Number: R0251
Ropivacaine
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- (S)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 250MG |
€74.00
|
1 | 8 |
|
| 1G |
€175.00
|
1 | 19 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | R0251 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__7H__2__6N__2O = 274.41 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Heat Sensitive |
| CAS RN | 84057-95-4 |
| Reaxys Registry Number | 5421606 |
| PubChem Substance ID | 468592799 |
| MDL Number | MFCD00864425 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Melting point | 148.0 to 152.0 °C |
| Specific rotation | -80.0 to -86.0 deg (C=2, methanol) |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 150 °C |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
| RTECS# | TM6082000 |
Transport Information:
| HS Number | 2933399990 |
Application
Ropivacaine: A Long Acting, Amide-Type Local Anesthetic
Ropivacaine, an S-enantiomer of bupivacaine [B3925 (hydrochloride)], is a long acting, amide-type local anesthetic with both anesthetic and analgesic effects. Ropivacaine, like other local anesthetics, causes reversible blockade of impulse propagation along nerve fibers by preventing the inward movement of sodium ions through the cell membrane of the nerve fibers. Furthermore, ropivacaine is more selective for neuronal sodium channels and less selective for myocardial sodium channels than racemic bupivacaine. (The product is for research purpose only.)
References
- Ropivacaine (a review)
- Pharmacology, toxicology, and clinical use of new long acting local anesthetics, ropivacaine and levobupivacaine (a review)
- Ropivacaine: a review of its pharmacology and clinical use
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.